6533b7cffe1ef96bd1259a7b
RESEARCH PRODUCT
Fluorescence in situ hybridization analysis does not increase detection rate for trisomy 8 in chronic myelomonocytic leukemia.
Javier GrauEva LumbrerasMaría AbáigarTeresa GonzálezIdoia AncínMaria Luisa MartinDavid IvarsJosé-joaquín DuarteJesús María Hernández-rivasRosa ColladoMaría José LarrayozFelix CarbonellNicolás Díaz VarelaNeus RuizMaría ÁNgeles PiñanFrancesc SoléSilvia SaumellMaría Rodríguez-riveraMercedes BotiaIsabel GranadaMaría José CalasanzIsabel MarugánMar TormoManuela Fernández-guijarroLourdes FlorensaCarme Pedrosubject
Cancer Researchmedicine.diagnostic_testChronic myelomonocytic leukemiaLeukemia Myelomonocytic ChronicTrisomyHematologyBiologyTrisomy 8medicine.diseaseClonal Hematopoietic Stem CellOncologyhemic and lymphatic diseasesmedicineCancer researchNeoplasmHumansDetection rateIn Situ Hybridization FluorescenceFluorescence in situ hybridizationChromosomes Human Pair 8description
Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic stem cell neoplasm characterized by overlapping myelodysplastic and myeloproliferative features. Diagnosis is based on persistent mo...
year | journal | country | edition | language |
---|---|---|---|---|
2014-04-15 | Leukemialymphoma |